Yantai Dongcheng Pharmaceutical Group Co., Ltd.
http://www.dcb-group.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Yantai Dongcheng Pharmaceutical Group Co., Ltd.
Radionuclide Therapy Developers Attract Investor Attention in March China Fundraising
China's Chengdu New Radiomedicine Technology and the radiotherapy CRDMO Mitro Biotech bagged a combined $94m in their respective new financing rounds during March. Meanwhile, Beijing Varnotech Biopharm secured $83m for its vaccine candidates for the prevention of herpes zoster and respiratory syncytial virus infections.
Company Information
- Industry
-
Pharmaceuticals
- Radiopharmaceuticals, Contrast Agents
-
Biotechnology
- Drug Discovery Technologies
- Other Names / Subsidiaries
-
- Yantai Dongcheng Biochemicals Co., Ltd.
- Yantai LNC Biotechnology Singapore Pte. Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice